Human Papilloma Virus (HPV)NCT06909370
Peer Education on HPV: Impact on Health Sciences Students' Knowledge, Awareness, and Concern
A study testing peer education in people with Human Papilloma Virus (HPV), run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
Trial summary
According to the World Health Organization (WHO), 400 million treatable sexually transmitted diseases (STDs) such as syphilis, chlamydia and human papillomavirus (HPV) occur each year in people aged 15-49, mostly in developing countries. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Human Papilloma Virus (HPV)
- What is being tested?
- peer education
- Type of treatment
- Vaccines, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 127 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 May 2024to 15 Mar 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- All individuals who are senior students in the Faculty of Health Sciences departments and who agree to participate in the study will be included in the study.
Who cannot join
- Individuals who did not complete the study and did not speak and understand Turkish were excluded from the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Peer Education for Human Papilloma Virus (HPV) on Knowledge, Awareness and Concern Levels of Students in the Faculty of Health Sciences
According to the World Health Organization (WHO), 400 million treatable sexually transmitted diseases (STDs) such as syphilis, chlamydia and human papillomavirus (HPV) occur each year in people aged 15-49, mostly in developing countries. As HPV is a sexually transmitted virus, it has been shown to be the most important aetiological factor in cervical cancer in women (99.7%). Vaccination and education of young people about sexuality and STDs are very important in the prevention of HPV. In this respect, the aim of this study was to find out the level of knowledge, concern and awareness of HPV infection among university students and to increase their awareness by informing them about the subject through their peers. The study was conducted as a pre-test and post-test one-group study. The sample of the study consisted of all final year students of Physiotherapy and Rehabilitation (85 students), Nutrition and Dietetics (60 students), Audiology (35 students), Child Development (80 students), Health Management (44 students) and Social Work (45 students) studying in the spring semester of the 2023-2024 academic year. The students were trained by the Gynaecology Nursing Intern student group (9 students) of the Department of Nursing. Data were collected using the Sociodemographic Characteristics Form, the HPV Knowledge Scale and the Human Papilloma Virus Awareness and Concern Level Scale (HPV-FAS). The relevant forms and the consent form were completed by the students before, after and one month after the training.
- Conditions
- Human Papilloma Virus (HPV)
- Being tested
- peer education
- Keywords
- HPV, peer education, awareness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
peer educationBehavioural
The training titled "The Effect of Peer Education on Human Papillomavirus (HPV) for Students in the Faculty of Health Sciences on Knowledge, Awareness, and Concern Levels" includes scientific and up-to-date information about HPV transmission methods, prevention, risk factors, treatment methods, and vaccination. The content of the training aims to provide students with accurate information about HPV, as well as highlight the negative health effects of the virus, particularly its association with serious diseases like cervical cancer. The training seeks to increase students' awareness of HPV and help them manage their levels of concern about the virus. Through the peer education method, students were able to interact with each other, thus providing a more effective learning experience.
| Study group | Role | What they receive |
|---|---|---|
| Sleep Hygiene Training | Experimental | Not described Receives: Behavioral: peer education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sociodemographic Characteristics Form
It consists of nine questions containing sociodemographic data of students, developed by the researchers.
Measured: Through study completion, an average of 6 months
HPV Knowledge Scale (HPV-KS)
The HPV-KS was developed in 2013 by Waller and colleagues to measure individuals' knowledge levels about HPV, the HPV vaccine, and screening tests. The scale examines whether individuals have previously heard about HPV, the HPV vaccine, and HPV screening tests, as well as the extent of their knowledge on these topics. The first subdimension of the HPV-KS consists of 16 items and assesses participants' general knowledge about HPV. The second subdimension includes six items and is related to HPV screening tests. The third subdimension consists of seven items and asks participants to respond to items about the HPV vaccine. The independent subdimension of the HPV-KS has been developed in three different forms for the HPV vaccination program conducted in three different countries. For each item in the HPV-KS, participants are expected to mark "Yes," "No," or "I don't know." The total score obtained from the HPV-KS ranges from 0 to 33.
Measured: Through study completion, an average of 6 months
Human Papillomavirus Awareness and Concern Scale (HPV-ACS)
Developed by Yılmaz Esencan and colleagues (2023), this scale is designed as a five-point Likert-type and consists of 19 items and three subdimensions. The subdimensions of the scale are "Concern about health," "Concern about being excluded," and "Awareness." The scale scores range from a minimum of 0 to a maximum of 76 points. A higher total score indicates a stronger awareness of HPV. The Cronbach's Alpha reliability coefficient of the original scale was determined to be 0.905.
Measured: Through study completion, an average of 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Apr 2025
- Study start1 May 2024
- Primary completion15 Jun 2024
- Study completion15 Mar 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Human Papilloma Virus (HPV)Studies of the same condition, open and under way.
- More trials run by Saglik Bilimleri UniversitesiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 127 participants (actual)
Sponsor and investigators
- Lead sponsor
- Saglik Bilimleri Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Beyzanur İşbay Aydemir, Istanbul Aydın University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06909370
- Sponsor's protocol ID
- 2024/04
- Status last verified
- Mar 2025
- First submitted
- 27 Mar 2025
- Last updated
- 3 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 3 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Peer Education for Human Papilloma Virus (HPV) on Knowledge, Awareness and Concern Levels of Students in the Faculty of Health Sciences
- ClinicalTrials.gov ID
- NCT06909370
- Acronym / sponsor ID
- 2024/04
- Conditions
- Human Papilloma Virus (HPV)
- Keywords
- HPV, peer education, awareness
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 127 participants (actual)
- Lead sponsor
- Saglik Bilimleri UniversitesiUniversity, hospital or other
- Study start
- 1 May 2024 (actual)
- Primary completion
- 15 Jun 2024 (actual)
- Study completion
- 15 Mar 2025 (actual)
- First posted
- 3 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
According to the World Health Organization (WHO), 400 million treatable sexually transmitted diseases (STDs) such as syphilis, chlamydia and human papillomavirus (HPV) occur each year in people aged 15-49, mostly in developing countries. As HPV is a sexually transmitted virus, it has been shown to be the most important aetiological factor in cervical cancer in women (99.7%). Vaccination and education of young people about sexuality and STDs are very important in the prevention of HPV. In this respect, the aim of this study was to find out the level of knowledge, concern and awareness of HPV infection among university students and to increase their awareness by informing them about the subject through their peers. The study was conducted as a pre-test and post-test one-group study. The sample of the study consisted of all final year students of Physiotherapy and Rehabilitation (85 students), Nutrition and Dietetics (60 students), Audiology (35 students), Child Development (80 students), Health Management (44 students) and Social Work (45 students) studying in the spring semester of the 2023-2024 academic year. The students were trained by the Gynaecology Nursing Intern student group (9 students) of the Department of Nursing. Data were collected using the Sociodemographic Characteristics Form, the HPV Knowledge Scale and the Human Papilloma Virus Awareness and Concern Level Scale (HPV-FAS). The relevant forms and the consent form were completed by the students before, after and one month after the training.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Sleep Hygiene Training | Experimental | Behavioral: peer education |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- All individuals who are senior students in the Faculty of Health Sciences departments and who agree to participate in the study will be included in the study.
Key exclusion criteria (1 listed)
- Individuals who did not complete the study and did not speak and understand Turkish were excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| peer educationThe training titled "The Effect of Peer Education on Human Papillomavirus (HPV) for Students in the Faculty of Health Sciences on Knowledge, Awareness, and Concern Levels" includes scientific and up-to-date information about HPV transmission methods, prevention, risk factors, treatment methods, and vaccination. The content of the training aims to provide students with accurate information about HPV, as well as highlight the negative health effects of the virus, particularly its association with serious diseases like cervical cancer. The training seeks to increase students' awareness of HPV and help them manage their levels of concern about the virus. Through the peer education method, students were able to interact with each other, thus providing a more effective learning experience. | Behavioural | Sleep Hygiene Training |
Primary outcome
Sociodemographic Characteristics Form
Time frame: Through study completion, an average of 6 months
It consists of nine questions containing sociodemographic data of students, developed by the researchers.
HPV Knowledge Scale (HPV-KS)
Time frame: Through study completion, an average of 6 months
The HPV-KS was developed in 2013 by Waller and colleagues to measure individuals' knowledge levels about HPV, the HPV vaccine, and screening tests. The scale examines whether individuals have previously heard about HPV, the HPV vaccine, and HPV screening tests, as well as the extent of their knowledge on these topics. The first subdimension of the HPV-KS consists of 16 items and assesses participants' general knowledge about HPV. The second subdimension includes six items and is related to HPV screening tests. The third subdimension consists of seven items and asks participants to respond to items about the HPV vaccine. The independent subdimension of the HPV-KS has been developed in three different forms for the HPV vaccination program conducted in three different countries. For each item in the HPV-KS, participants are expected to mark "Yes," "No," or "I don't know." The total score obtained from the HPV-KS ranges from 0 to 33.
Human Papillomavirus Awareness and Concern Scale (HPV-ACS)
Time frame: Through study completion, an average of 6 months
Developed by Yılmaz Esencan and colleagues (2023), this scale is designed as a five-point Likert-type and consists of 19 items and three subdimensions. The subdimensions of the scale are "Concern about health," "Concern about being excluded," and "Awareness." The scale scores range from a minimum of 0 to a maximum of 76 points. A higher total score indicates a stronger awareness of HPV. The Cronbach's Alpha reliability coefficient of the original scale was determined to be 0.905.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Apr 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Human Papilloma Virus (HPV)
Not yet recruitingPhase 2
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV)
RecruitingObservational study
The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
EBV, HSV
RecruitingObservational study
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
Cervical Cancer, Cervical Dysplasia
RecruitingObservational study
Lived Experiences of Women Diagnosed With HPV Infection
Human Papillomavirus Infection
Recruiting
Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda
HIV (Human Immunodeficiency Virus), HPV
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing peer education in people with Human Papilloma Virus (HPV), run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sociodemographic Characteristics Form (time frame: Through study completion, an average of 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2025.